Rapid screening of SARS-CoV-2 variants, a key tool for pandemic surveillance.

Publication date: Jul 08, 2023

The utility of reverse transcription-polymerase chain reaction (RT-PCR) in analysis SARS-COV-2 variants was evaluated. RT-PCR tests were used to analyse the majority of new SARS-CoV-2 cases (n = 9315) in a tertiary hospital (Madrid, Spain) throughout 2021. Subsequently, whole genome sequencing (WGS) was conducted on 10. 8% of these samples (n = 1002). Notably, the Delta and Omicron variants emerged rapidly. There were no discrepancies between RT-PCR and WGS results. Continuous surveillance of SARS-CoV-2 variants is essential, and RT-PCR is a highly useful method, specially during periods of high COVID-19 incidence. This feasible technique can be implemented in all SARS-CoV-2 laboratories. However, WGS remains the gold standard method for comprehensive detection of all existing SARS-CoV-2 variants.

Open Access PDF

Concepts Keywords
Pandemic Cov
Pcr Key
Spain Pandemic
Pcr
Polymerase
Rapid
Reverse
Rt
Sars
Screening
Surveillance
Transcription
Utility
Variants
Wgs

Semantics

Type Source Name
disease MESH COVID-19
drug DRUGBANK Gold
drug DRUGBANK Coenzyme M
disease MESH sid
drug DRUGBANK Spinosad
disease IDO susceptibility
disease VO vaccinated
disease MESH emergency
disease IDO process
disease VO USA
drug DRUGBANK Lauric Acid
disease VO frequency
disease IDO assay
drug DRUGBANK Etoperidone
disease VO time
disease VO gene
drug DRUGBANK Troleandomycin
disease MESH clinical significance
disease MESH immunocompromised patient
pathway REACTOME Reproduction

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *